Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

IN B00001

Drug Profile

IN B00001

Alternative Names: IN-B00001; IN-B002

Latest Information Update: 07 Jan 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator HK inno.N
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Smallpox

Highest Development Phases

  • Phase I Smallpox

Most Recent Events

  • 07 Jan 2025 Phase-I clinical trials in Smallpox (Prevention) (Parenteral), prior to January 2025 (HK inno.N pipeline, January 2025)
  • 29 Mar 2024 Preclinical development in Smallpox (Prevention) is ongoing in South Korea (unspecified route) prior to March 2024 (HK inno.N pipeline, March 2024)
  • 28 Feb 2024 No recent reports of development identified for preclinical development in Smallpox(Prevention) in South Korea

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top